Skip to main content

PSTI Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Pluristem Therapeutics Inc. News

Biotech Movers: Disappointment for Bristol-Myers Kidney Combo Boosts Exelixis

Previously studies already showed improvement from use of Exelixis's Cabometyx over Pfizer's Sutent in treating kidney cancer patients.

Stocks turn mixed again, nasdaq remains on track for record close

Stocks turn mixed on Tuesday, though the Nasdaq remains on track to set to record a close for its third day in a row.

Stocks turn higher, Nasdaq trades above record closing high

Stocks turn higher Tuesday as crude oil declines and the fourth-quarter earnings season draws closer.

Stock futures little changed as oil prices level off

Stock futures are little changed on Tuesday as investors await news from a press conference Wednesday with President-elect Donald Trump. Oil prices level off.

Breaking News

Ford Makes a Major Change

The legacy automaker has just made a decision that will affect consumers buying its electric vehicles via a lease.

Tesla Q2 Deliveries Slump To 254,695 As Shanghai Shutdown, Supply Chain Snarls Take Toll

Tesla said it had a record rate of production in June, but supply chain disruption and the closure of its Shanghai gigafactory triggered a slump in Q2 deliveries.

Summers, Others Cite Growing Chance of Recession

GDP shrank an annualized 1.6% in the first quarter, and some experts anticipate another drop in the second quarter.

Coinbase Faces A New Scandal

The platform denies selling proprietary customer data and announces it is expanding into several European countries.